TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Xellia Pharmaceuticals AS
Closing information (x1000 DKK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 58,053 | 58,534 | 63,184 |
Financial expenses | 14 | 25 | 6,597 |
Earnings before taxes | 19,176 | 20,938 | 5,628 |
Total assets | 454,665 | 428,417 | 416,405 |
Current assets | 113,454 | 91,997 | 78,699 |
Current liabilities | 16,049 | 15,414 | 16,778 |
Equity capital | 433,974 | 407,652 | 393,533 |
- share capital | 169,088 | 166,222 | 168,910 |
Employees (average) | 43 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 95.4% | 95.2% | 94.5% |
Turnover per employee | 1,469 | ||
Profit as a percentage of turnover | 33.0% | 35.8% | 8.9% |
Return on assets (ROA) | 4.2% | 4.9% | 2.9% |
Current ratio | 706.9% | 596.8% | 469.1% |
Return on equity (ROE) | 4.4% | 5.1% | 1.4% |
Change turnover | -1,491 | -3,644 | -651 |
Change turnover % | -3% | -6% | -1% |
Chg. No. of employees | -4 | ||
Chg. No. of employees % | -9% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.